Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Bone Remodeling01:40

Bone Remodeling

34.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-21 isoform transgenic mice spontaneously develop mammary tumors: possible involvement of IL-21-induced osteopontin expression in tumorigenesis.

Frontiers in immunology·2026
Same author

Correction: IL-21 isoform transgenic mice spontaneously develop mammary tumors: possible involvement of IL-21-induced osteopontin expression in tumorigenesis.

Frontiers in immunology·2026
Same author

Increased macrophage autophagy with unique polarization in rheumatoid synovium.

Autophagy·2026
Same author

Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma.

PloS one·2026
Same author

Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.

British journal of cancer·2025
Same author

Effusion Reduction after Early Trastuzumab Deruxtecan Therapy for Unresectable HER2-Low Breast Cancer in an Older Patient: A Case Report.

Surgical case reports·2025

Related Experiment Video

Updated: Apr 26, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.1K

[Mechanism for bone metastasis].

Mitsuru Futakuchi1, Shinya Sato

  • 1Graduate School of Medical Sciences, Nagoya City University, Japan.

Clinical Calcium
|July 29, 2014
PubMed
Summary
This summary is machine-generated.

Bone metastasis involves complex interactions within the bone microenvironment, including receptor activator of NF-κB ligand (RANKL) and TGFβ. Epigenetics contributes to cancer cell drug resistance during this process.

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.4K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Related Experiment Videos

Last Updated: Apr 26, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.1K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.4K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Context:

  • Bone metastasis is a critical determinant of cancer patient survival.
  • The bone microenvironment presents unique challenges and interactions for cancer cells.
  • Understanding these interactions is key to developing effective treatments.

Purpose:

  • To elucidate the mechanisms driving cancer cell adaptation and survival in the bone microenvironment.
  • To investigate the role of tumor-stromal interactions, specifically RANKL and TGFβ, in bone metastasis.
  • To explore the contribution of epigenetics to drug resistance in bone metastatic cancer cells.

Summary:

  • Cancer cells acquire malignant traits through a series of adaptive steps within the bone microenvironment.
  • Receptor activator of NF-κB ligand (RANKL) mediates tumor-stromal interactions, while released TGFβ from bone matrix destruction promotes cancer cell proliferation.
  • Epigenetic modifications, independent of gene mutations, are implicated in the development of drug resistance.

Impact:

  • Provides insights into the complex biology of bone metastasis.
  • Identifies key molecular players (RANKL, TGFβ, epigenetics) involved in cancer progression and drug resistance.
  • Lays the groundwork for developing novel molecular-targeted therapies to combat bone metastasis and improve patient outcomes.